Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/204.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Virus or component thereof
Description: Subject matter involving a virus or a component of a virus.

Sub-classes under this class:

Class Number Class Name Patents
424/233.1 Adenoviridae, adeno-like virus, or parvoviridae (e.g., adenovirus, canine parvovirus, mink enteritis virus, hemorrhagic enteritis virus, feline panleukopenia virus, egg drop syndrome virus, etc.) 214
424/216.1 Calciviridae or picornaviridae, except hepatitis a virus (e.g., foot-and- mouth disease virus (fmdv), coxsackievirus, echovirus, avian encephalomyelitis virus, mengovirus, etc.) 99
424/221.1 Coronaviridae (e.g., neonatal calf diarrhea virus, feline infectious peritonitis virus, canine coronavirus, etc.) 76
424/225.1 Hepatitis virus (e.g., infectious canine hepatitis virus, duck hepatitis virus, mouse hepatitis virus, etc.) 76
424/229.1 Herpetoviridae (e.g., herpesvirus, marek`s disease virus, laryngotracheitis virus, infectious bovine rhinotracheitis virus (ibr), infectious pustular vulvovaginitis virus, bovine herpes virus type 1, aujeszky`s disease virus, feline rhinotracheitis virus, feline herpes virus, etc.) 340
424/209.1 Orthomyxoviridae (e.g., influenza virus, fowl plague virus, etc.) 318
424/211.1 Paramyxoviridae (e.g., parainfluenza virus, respiratory syncytial virus, rinderpest virus, sendai virus, canine tracheobronchitis virus, turkey rhinotracheitis virus, etc.) 256
424/232.1 Poxviridae (e.g., smallpox virus, avian pox virus, fowlpox virus, rabbit myxoma virus, vaccinia virus, etc.) 252
424/205.1 Reassortant or deletion mutant virus 255
424/215.1 Reoviridae (e.g., rotavirus, reovirus, orbivirus, avian proventriculitis virus, bluetongue virus, colorado tick fever virus, etc.) 139
424/207.1 Retroviridae (e.g., feline leukemia virus, bovine leukemia virus, avian leukosis virus, equine infectious anemia virus, rous sarcoma virus, htlv-i, etc.) 195
424/224.1 Rhabdoviridae (e.g., rabies virus, vesicular stomatitis virus, etc.) 114
424/218.1 Togaviridae or flaviviridae, except hepatitis c virus (e.g., yellow fever virus, bovine viral diarrhea virus, dengue virus, equine viral arteritis virus, equine encephalitis virus, japanese b encephalitis virus, sindbis virus, flavivirus, etc.) 319

Patents under this class:

Patent Number Title Of Patent Date Issued
8709730 Methods of preventing and treating viral infections by inhibiting the deISGylation activity of OTU domain-containing viral proteins Apr. 29, 2014
8703142 Methods to bypass CD4+ cells in the induction of an immune response Apr. 22, 2014
8691239 Influenza hemagglutinin and neuraminidase variants Apr. 8, 2014
8691234 Vaccine formulation potentiated by the combination of DNA and an antigen Apr. 8, 2014
8685721 Stable constitutively high expression vector for preparing HPV vaccine and recombinant lactic acid bacteria transformed thereby Apr. 1, 2014
8685409 Influenza T-cell immunization against diverse influenza A viruses Apr. 1, 2014
8673319 Chimpanzee adenovirus vaccine carriers Mar. 18, 2014
8673315 Method for producing vaccinal viral strain of a virus of the reoviridae family Mar. 18, 2014
8663653 Efficient cell culture system for hepatitis C virus genotype 2B Mar. 4, 2014
8652486 Neutralizing immunogen (NimIV) of rhinovirus and its use for vaccine applications Feb. 18, 2014
8652482 HPV E6 protein T cell epitopes and uses thereof Feb. 18, 2014
8647643 Farnesoid-X-receptor antagonist as a vaccine adjuvant Feb. 11, 2014
8647637 Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs Feb. 11, 2014
8628809 Method of inducing mucosal immune response to antigen with Dioscorea polysaccharides adjuvant Jan. 14, 2014
8623379 Compositions and methods for generating an immune response Jan. 7, 2014
8617566 Composition comprising VLP and amyloid beta peptide Dec. 31, 2013
8613936 Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements Dec. 24, 2013
8613934 Cellular and viral inactivation Dec. 24, 2013
8597664 Endogenous adjuvant molecules and uses thereof Dec. 3, 2013
8597661 Neuraminidase-deficient live influenza vaccines Dec. 3, 2013
8592197 Functional influenza virus-like particles (VLPs) Nov. 26, 2013
8586364 Cells and methodology to generate non-segmented negative-strand RNA viruses Nov. 19, 2013
8586034 Cytomegalovirus disintegrin-like peptides Nov. 19, 2013
8580270 Respiratory synctial virus (RSV) sequences for protein expression and vaccines Nov. 12, 2013
8574593 Influenza hemagglutinin and neuraminidase variants Nov. 5, 2013
8574590 Lipoparticles comprising proteins, methods of making, and using the same Nov. 5, 2013
8568738 Virus-modified bacteria ghosts Oct. 29, 2013
8557246 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof Oct. 15, 2013
8541003 Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using Sep. 24, 2013
8535687 Smallpox DNA vaccine and the antigens therein that elicit an immune response Sep. 17, 2013
8529906 Compositions for inducing immune responses Sep. 10, 2013
8517723 Methods for drying a viral vaccine Aug. 27, 2013
8512712 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions Aug. 20, 2013
8512711 VLP based vaccine delivery system Aug. 20, 2013
8506969 Efficient cell culture system for hepatitis C virus genotype 7a Aug. 13, 2013
8496941 Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same Jul. 30, 2013
8496940 Prevention and treatment of sub-clinical PCVD Jul. 30, 2013
8486685 Cellular permissivity factor for viruses and uses thereof Jul. 16, 2013
8486421 Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use Jul. 16, 2013
8481051 Cytotoxic T-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof Jul. 9, 2013
8475806 High titer recombinant influenza viruses for vaccines and gene therapy Jul. 2, 2013
8475805 Methods of reducing concomitant infections in pigs with a PCV2 antigen Jul. 2, 2013
8475804 Compositions and methods for treatment of filovirus-mediated diseases Jul. 2, 2013
8470372 Material with immunogenicity Jun. 25, 2013
8470342 Methods of altering an immune response induced by CpG oligodeoxynucleotides Jun. 25, 2013
8465960 Influenza B viruses with reduced sensitivity to neuraminidase inhibitors Jun. 18, 2013
8465748 Vaccine compositions and methods containing an immunogen derived from equine arteritis virus Jun. 18, 2013
8460680 Polyvalent chimeric rubella virus-based vaccines Jun. 11, 2013
8460678 Use of triplex structure DNA in transferring nucleotide sequences Jun. 11, 2013
8460676 Composition comprising VLP and amyloid beta peptide Jun. 11, 2013

  Recently Added Patents
Proton conducting electrolytes with cross-linked copolymer additives for use in fuel cells
Motion compensated overlay
Method and apparatus for accessing coconut water
Vaccine composition against Streptococcus pyogenes
Autobrake and decel control built-in test equipment
Method for generating optical codes for a print-context
Audio and music data transmission medium and transmission protocol
  Randomly Featured Patents
Multilayer capacitor
Method for feedforward corrections for off-specification conditions
Controlling vehicle lateral lane positioning
Processes for producing 1,6-hexanediols
Error correction for flash memory
Method of making end frames for upholstered furniture
Four-wheel drive vehicle
Soybean cultivar S080190
Attachment devices and method for a dental applicance
Method for implanting soft tissue